Abstract
Cholestasis, or impaired bile flow, is an important but poorly understood manifestation of liver disease. Two clinically distinct forms of inherited cholestasis, benign recurrent intrahepatic cholestasis (BRIC) and progressive familial intrahepatic cholestasis type 1 (PFIC1), were previously mapped to 18q21. Haplotype analysis narrowed the candidate region for both diseases to the same interval of less than 1 cM, in which we identified a gene mutated in BRIC and PFIC1 patients. This gene (called FIC1) is the first identified human member of a recently described subfamily of P-type ATPases; ATP-dependent aminophospholipid transport is the previously described function of members of this subfamily. FIC1 is expressed in several epithelial tissues and, surprisingly, more strongly in small intestine than in liver. Its protein product is likely to play an essential role in enterohepatic circulation of bile acids; further characterization of FIC1 will facilitate understanding of normal bile formation and cholestasis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Lidofsky, S.D. & Scharschmidt, B.F. in Sleisenger & Fordtran's Gastrointestinal and Liver Disease: Pathophysiology, Diagnosis and Management, 6th ed (eds Feldman, M.f Scharschmidt, B.F. & Sleisenger, W.B.) 220-234 (Saunders Cornpany, Philadelphia, 1997).
Summerskill, W.H.J. The syndrome of benign recurrent cholestasis. Am. J. Med. 38,298–305(1965).
Bijleveld, C.M., Vonk, R.J., Kuipers, F., Havinga, R. & Fernandes, J. Benign recurrent intrahepatic cholestasis: a long-term follow-up study of two patients. Hepatology. 9, 532–537 (1989).
De Koning, T.J. et al. Autosomal-recessive inheritance of benign recurrent intrahepatic cholestasis. Am. J. Med. Genet. 57, 479–482 (1995).
Clayton, R.J., Iber, F.L., Ruebner, B.H. & McKusick, V.A. Byler disease: Fatal familial intrahepatic cholestasis in an Amish kindred. Amer. J. Dis. Child. 117, 112–124 (1969).
Linarelli, L.G., Williams, C.N. & Phillips, M.J. Byler's disease: fatal intrahepatic cholestasis. J. Pediatr. 81, 484–492 (1972).
Strautnieks, S.S. et al. Identification of a locus for progressive familial intrahepatic cholestasis PFIC2 on chromosome 2q24. Am. J. Hum. Genet. 61, 630–633 (1997).
Bull, L.N. et al. Genetic and morphological findings in progressive familial intrahepatic cholestasis (Byler disease [PFIC-1] and Byler syndrome): evidence for heterogeneity. Hepatology 26, 155–164 (1997).
Bijleveld, C.M.A. et al. Benign recurrent intrahepatic cholestasis: altered bile acid metabolism. Gastroenterol. 97,427–432 (1989).
Jacquemin, E., Dumont, M., Bernard, O., Erlinger, S. & Hadchouel, M. Evidence for defective primary bile acid secretion in children with progressive familial intrahepatic cholestasis (Byler disease). Eur. J. Pediatr. 153, 424–428 (1994).
Houwen, R.H.J. et al. Genome screening by searching for shared segments: mapping a gene for benign recurrent intrahepatic cholestasis. Nature Genet. 8, 380–386 (1994).
Sinke, R.J. et al. Benign recurrent intrahepatic cholestasis (BRIC): evidence of genetic heterogeneity and delimitation of the BRIC locus to a 7-cM interval between D18S69 and D18S64. Hum. Genet. 100, 382–387 (1997).
Carlton, V.E., Knisely, A.S. & Freimer, N.B. Mapping of a locus for progressive familial intrahepatic cholestasis (Byler disease) to 18q21-q22, the benign recurrent intrahepatic cholestasis region. Hum. Mol. Genet. 4, 1049–1053 (1995).
Muller, M. & Jansen, P.L. Molecular aspects of hepatobiliary transport. Am. J. Physiol. 272, G1285–1303 (1997).
Tang, X., Halleck, M.S., Schlegel, R.A. & Williamson, P. A subfamily of P-type ATPases with aminophospholipid transporting activity. Science 272, 1495–1497 (1996).
Fagan, M.J. & Saier, M.H., ATPases of eukaryotes and bacteria: sequence analyses and construction of phylogenetic trees. J. Mol. Evol. 38, 57–99 (1994).
Lutsenko, S. & Kaplan, J.H. Organization of P-type ATPases: significance of structural diversity. Biochem. 34, 15607–15613 (1995).
Moller, J.V., Juul, B. & le Maire, M. Structural organization, ion transport, and energy transduction of P-type ATPases. Biochim. Biophys. Acta 1286, 1–51 (1996).
Hofman, F. Sleisenger & Fordtran's Gastrointestinal and Liver Disease: Pathophysiology, Diagnosis and Management , 6th ed (eds Feldman, M., Scharschmidt, B.F. & Sleisenger, W.B.) 937–947 (Saunders Company, Philadelphia, 1997).
Vlahcevic, Z.R., Heuman, D.M. & Hylemon, P.B. in Hepatology: A Textbook of Liver Disease , 3rd ed (eds Zakim, D. & Boyer, T.D.) 376–417 (Saunders Company, Philadelphia, 1996).
Tazawa, Y., Yamada, M., Nakagawa, M., Konno, T. & Tada, K. Bile acid profiles in siblings with progressive intrahepatic cholestasis: absence of biliary chenodeoxycholate. J. Pediatr. Gastroenterol. Nutr. 4, 32–37 (1985).
Williamson, P. & Schlegel, R.A. Back and forth: the regulation and function of transbilayer phospholipid movement in eukaryotic cells. Mol. Membr. Biol. 11, 199–216 (1994).
Zhao, J., Sims, P.J. & Wiedmer, T. Production and characterization of a mutant cell line defective in aminophospholipid translocase. Biochim. Biophys. Acta 1357,57–64 (1997)
Smit, J.J. et al. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 75,451–462 (1993).
Ruetz, S. & Gros, P. Phosphatidylcholine translocase: a physiological role for the mdr2 gene. Cell 77, 1071–1081 (1994).
van Helvoort, A. et al. MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates Phosphatidylcholine. Cell 87, 507–517 (1996).
de Vree, M.L. et al. Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. Proc. Natl. Acad. Sci. USA 95, 282–287 (1998).
Knisely, A.S. et al. Byler's syndrome. Arch. Dis. Child. 77, 276–277 (1997).
Bourke, B. et al. Byler-like familial cholestasis in an extended kindred. Arch. Dis. Child. 75, 223–227 (1996).
Lloyd-Still, J.D. Familial cholestasis with elevated sweat electrolyte concentrations. J. Pediatr. 99, 580–583 (1981).
loannou, I. et al. A new bacteriophage Pi-derived vector for the propagation of large human DNA fragments. Nature Genet. 6, 84–89 (1994).
Wu, C., Zhu, S., Simpson, S. & de Jong, P.J. DOP-vector PCR: a method for rapid isolation and sequencing of insert termini from PAC clones. Nucleic Acids Res. 24, 2614–2615 (1996).
Kyte, J. & Doolittle, R.F. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157, 105–132 (1982).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bull, L., van Eijk, M., Pawlikowska, L. et al. A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis. Nat Genet 18, 219–224 (1998). https://doi.org/10.1038/ng0398-219
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ng0398-219
This article is cited by
-
Intestinal Atp8b1 dysfunction causes hepatic choline deficiency and steatohepatitis
Nature Communications (2023)
-
Angeborene Cholestasesyndrome im Erwachsenenalter: Relevantes für Diagnostik und Therapie
Die Gastroenterologie (2023)
-
Die intrahepatische, familiäre Cholestase – Manifestation bei einer Jugendlichen mit Pruritus und Ikterus nach Beginn oraler Kontrazeption
Monatsschrift Kinderheilkunde (2023)
-
Atp8a1 deletion increases the proliferative activity of hematopoietic stem cells by impairing PTEN function
Cellular Oncology (2023)
-
The role of phosphatidylserine on the membrane in immunity and blood coagulation
Biomarker Research (2022)